76 Chapter 4 4.8 REFERENCES 1. Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol; 2019;18:684–696. https://doi.org/10.1016/S14744422(19)30079-1 2. Snyder HM, Corriveau RA, Craft S, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimers Dement; 2015;11:710–717. https://doi. org/10.1016/j.jalz.2014.10.008 3. Jansma A, Bresser J de, Schoones JW, Heemst D van, Akintola AA. Sporadic cerebral small vessel disease and cognitive decline in healthy older adults: A systematic review and meta-analysis. Journal of Cerebral Blood Flow & Metabolism. 2024;0:1-20. doi:10.1177/0271678X241235494 4. Alber J, Alladi S, Bae H, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer’s & Dementia: Translational Research & Clinical Interventions; 2019;5:107–117. https://doi. org/10.1016/j.trci.2019.02.001 5. Ghaznawi R, Geerlings M, Jaarsma-Coes M, Hendrikse J, de Bresser J. Association of White Matter Hyperintensity Markers on MRI and Long-term Risk of Mortality and Ischemic Stroke. Neurology; 2017;96:e2172-2183. https://doi.org/10.1212/WNL.0000000000011827 6. Keller JA, Sigurdsson S, Klaassen K, et al. White matter hyperintensity shape is associated with long-term dementia risk. Alzheimers Dement. 2023;19(12):5632-5641. https://doi. org/10.1002/alz.13345 7. De Bresser J, Kuijf HJ, Zaanen K, et al. White matter hyperintensity shape and location feature analysis on brain MRI; Proof of principle study in patients with diabetes. Sci Rep. 2018;8: 8:1893. https://doi.org/10.1038/s41598-018-20084-y 8. Harris TB, Launer LJ, Eiriksdottir G, et al. Age, gene/environment susceptibility-reykjavik study: Multidisciplinary applied phenomics. Am J Epidemiol. Am J Epidemiol; 2007;165:1076– 1087. https://doi.org/10.1093/aje/kwk115 9. Schmidt P. Bayesian inference for structured additive regression models for large-scale problems with applications to medical imaging. Maximilians-Universität München; 2017. 10. Saczynski JS, Jónsdóttir MK, Garcia ME, et al. Cognitive Impairment: An Increasingly Important Complication of Type 2 DiabetesThe Age, Gene/Environment Susceptibility– Reykjavik Study. Am J Epidemiol. 2008;168:1132–1139. https://dx.doi.org/10.1093/aje/ kwn228. 11. Ding J, Sigurðsson S, Jónsson P V., et al. Space and location of cerebral microbleeds, cognitive decline, and dementia in the community. Neurology. 2017;88:2089–2097. https:// doi.org/10.1212/WNL.0000000000003983 12. Valsdóttir V, Magnúsdóttir BB, Chang M, et al. Cognition and brain health among older adults in Iceland: the AGES-Reykjavik study. Geroscience. 2022;44:2785–2800. https://doi. org/10.1007/s11357-022-00642-z 13. Delis D, Kramer J, Kaplan E, et al. California Verbal Learning Test Manual—Adult Version. New York, NY: Psychological Corporation; 1987. 14. Wechsler D. Wechsler Adult Intelligence Scale. New York, NY: Psychological Corporation; 1955. 15. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994;5:266–281. https://doi. org/10.1159/000106735 16. Salthouse TA, Babcock RL. Decomposing Adult Age Differences in Working Memory. Dev Psychol. 1991;27:763–776. https://psycnet.apa.org/doi/10.1037/0012-1649.27.5.76318
RkJQdWJsaXNoZXIy MTk4NDMw